Suppr超能文献

伴有胸腺分化的甲状腺恶性肿瘤:罕见的SETTLE和CASTLE肿瘤的预后

Thyroid Malignancies With Thymic Differentiation: Outcomes of Rare SETTLE and CASTLE Tumors.

作者信息

Tapescu Iulia, Kohler Abigail, Sangal Neel R, Brant Jason A, Brody Robert M, Chao Timothy, Carey Ryan M

机构信息

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Head Neck. 2025 Mar;47(3):899-905. doi: 10.1002/hed.27969. Epub 2024 Nov 4.

Abstract

BACKGROUND

Spindle epithelial tumors with thymus-like differentiation (SETTLE) and carcinomas showing thymus-like differentiation (CASTLE) are rare intrathyroid tumors.

METHODS

This retrospective cohort study included patients diagnosed with SETTLE, CASTLE, and papillary thyroid carcinoma (PTC) from 2004 to 2020 within the National Cancer Database (NCDB). Demographic, tumor, and treatment characteristics were compared. Overall survival (OS) was analyzed using the Kaplan-Meier method and Cox regression models.

RESULTS

This study identified 19 patients with CASTLE, 11 with SETTLE, and 483 474 with PTC. CASTLE and SETTLE patients had larger tumors, lymphovascular invasion, and positive surgical margins. They were rarely treated with radioactive iodine treatment but frequently received external beam radiation and chemotherapy. Five-year OS was significantly lower for CASTLE and SETTLE compared to PTC. SETTLE was associated with an increased risk of death.

CONCLUSION

SETTLE and CASTLE are rare intrathyroid tumors with worse survival compared to PTC, often managed with radiation, chemotherapy, and surgery.

摘要

背景

具有胸腺样分化的梭形上皮肿瘤(SETTLE)和显示胸腺样分化的癌(CASTLE)是罕见的甲状腺内肿瘤。

方法

这项回顾性队列研究纳入了2004年至2020年期间在国家癌症数据库(NCDB)中被诊断为SETTLE、CASTLE和甲状腺乳头状癌(PTC)的患者。比较了人口统计学、肿瘤和治疗特征。使用Kaplan-Meier方法和Cox回归模型分析总生存期(OS)。

结果

本研究确定了19例CASTLE患者、11例SETTLE患者和483474例PTC患者。CASTLE和SETTLE患者的肿瘤更大,有淋巴管侵犯和手术切缘阳性。他们很少接受放射性碘治疗,但经常接受外照射放疗和化疗。与PTC相比,CASTLE和SETTLE的5年总生存期显著更低。SETTLE与死亡风险增加相关。

结论

SETTLE和CASTLE是罕见的甲状腺内肿瘤,与PTC相比生存期更差,通常采用放疗、化疗和手术进行治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b390/11816565/253bb7a2c3e9/HED-47-899-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验